SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-026764
Filing Date
2018-05-10
Accepted
2018-05-09 20:01:11
Documents
58
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tv493232_10q.htm 10-Q 755625
2 EXHIBIT 31.1 tv493232_ex31-1.htm EX-31.1 11109
3 EXHIBIT 31.2 tv493232_ex31-2.htm EX-31.2 10947
4 EXHIBIT 32.1 tv493232_ex32-1.htm EX-32.1 4248
5 EXHIBIT 32.2 tv493232_ex32-2.htm EX-32.2 4204
12 GRAPHIC tv493232_img1.jpg GRAPHIC 47236
13 GRAPHIC tv493232_img2.jpg GRAPHIC 81660
  Complete submission text file 0001144204-18-026764.txt   4022715

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT iova-20180331.xml EX-101.INS 686461
7 XBRL TAXONOMY EXTENSION SCHEMA iova-20180331.xsd EX-101.SCH 37913
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iova-20180331_cal.xml EX-101.CAL 26464
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iova-20180331_def.xml EX-101.DEF 253487
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE iova-20180331_lab.xml EX-101.LAB 283133
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iova-20180331_pre.xml EX-101.PRE 284410
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 18820145
SIC: 2836 Biological Products, (No Diagnostic Substances)